1550P Survival outcomes in phase I trial combining the STING agonist ulevostinag ± pembrolizumab in solid tumors (MK1454-001).

Saved in:
Bibliographic Details
Title: 1550P Survival outcomes in phase I trial combining the STING agonist ulevostinag ± pembrolizumab in solid tumors (MK1454-001).
Authors: Llop Serna, S.1 (AUTHOR), Jimenez Labaig, P.1 (AUTHOR), Micheletto, I.1 (AUTHOR), Rullan Iriarte, A.J.2 (AUTHOR), Ouali, K.3 (AUTHOR), Champiat, S.4 (AUTHOR), Romano, E.5 (AUTHOR), Bastien, E.6 (AUTHOR), Golan, T.7 (AUTHOR), Gomez-Roca, C.A.8 (AUTHOR), Perets, R.9 (AUTHOR), Wong, D.J.10 (AUTHOR), Harrington, K.J.11 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS926-S926. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189419973
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 1550P Survival outcomes in phase I trial combining the STING agonist ulevostinag ± pembrolizumab in solid tumors (MK1454-001).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Llop+Serna%2C+S%2E%22">Llop Serna, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jimenez+Labaig%2C+P%2E%22">Jimenez Labaig, P.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Micheletto%2C+I%2E%22">Micheletto, I.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rullan+Iriarte%2C+A%2EJ%2E%22">Rullan Iriarte, A.J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ouali%2C+K%2E%22">Ouali, K.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Champiat%2C+S%2E%22">Champiat, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Romano%2C+E%2E%22">Romano, E.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bastien%2C+E%2E%22">Bastien, E.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Golan%2C+T%2E%22">Golan, T.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gomez-Roca%2C+C%2EA%2E%22">Gomez-Roca, C.A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Perets%2C+R%2E%22">Perets, R.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wong%2C+D%2EJ%2E%22">Wong, D.J.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Harrington%2C+K%2EJ%2E%22">Harrington, K.J.</searchLink><relatesTo>11</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS926-S926. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419973
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.08.2181
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S926
    Titles:
      – TitleFull: 1550P Survival outcomes in phase I trial combining the STING agonist ulevostinag ± pembrolizumab in solid tumors (MK1454-001).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Llop Serna, S.
      – PersonEntity:
          Name:
            NameFull: Jimenez Labaig, P.
      – PersonEntity:
          Name:
            NameFull: Micheletto, I.
      – PersonEntity:
          Name:
            NameFull: Rullan Iriarte, A.J.
      – PersonEntity:
          Name:
            NameFull: Ouali, K.
      – PersonEntity:
          Name:
            NameFull: Champiat, S.
      – PersonEntity:
          Name:
            NameFull: Romano, E.
      – PersonEntity:
          Name:
            NameFull: Bastien, E.
      – PersonEntity:
          Name:
            NameFull: Golan, T.
      – PersonEntity:
          Name:
            NameFull: Gomez-Roca, C.A.
      – PersonEntity:
          Name:
            NameFull: Perets, R.
      – PersonEntity:
          Name:
            NameFull: Wong, D.J.
      – PersonEntity:
          Name:
            NameFull: Harrington, K.J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2025 Supplement 2
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 36
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1